These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 35345960)
1. Pyrimidine-5-carbonitrile based potential anticancer agents as apoptosis inducers through PI3K/AKT axis inhibition in leukaemia K562. El-Dydamony NM; Abdelnaby RM; Abdelhady R; Ali O; Fahmy MI; R Fakhr Eldeen R; Helwa AA J Enzyme Inhib Med Chem; 2022 Dec; 37(1):895-911. PubMed ID: 35345960 [TBL] [Abstract][Full Text] [Related]
2. In vitro antiproliferative activity of 2,3-dihydroxy-9,10-anthraquinone induced apoptosis against COLO320 cells through cytochrome c release caspase mediated pathway with PI3K/AKT and COX-2 inhibition. Balachandran C; Emi N; Arun Y; Yamamoto N; Duraipandiyan V; Inaguma Y; Okamoto A; Ignacimuthu S; Al-Dhabi NA; Perumal PT Chem Biol Interact; 2016 Apr; 249():23-35. PubMed ID: 26915975 [TBL] [Abstract][Full Text] [Related]
3. Altersolanol B, a fungal tetrahydroanthraquinone, inhibits the proliferation of estrogen receptor-expressing (ER+) human breast adenocarcinoma by modulating PI3K/AKT, p38/ERK MAPK and associated signaling pathways. Siraj MA; Jacobs AT; Tan GT Chem Biol Interact; 2022 May; 359():109916. PubMed ID: 35346647 [TBL] [Abstract][Full Text] [Related]
4. Towards the small and the beautiful: a small dibromotyrosine derivative from Pseudoceratina sp. sponge exhibits potent apoptotic effect through targeting IKK/NFκB signaling pathway. Su JH; Chen YC; El-Shazly M; Du YC; Su CW; Tsao CW; Liu LL; Chou Y; Chang WB; Su YD; Chiang MY; Yeh YT; Lu MC Mar Drugs; 2013 Aug; 11(9):3168-85. PubMed ID: 24065159 [TBL] [Abstract][Full Text] [Related]
5. Mesothelin confers pancreatic cancer cell resistance to TNF-α-induced apoptosis through Akt/PI3K/NF-κB activation and IL-6/Mcl-1 overexpression. Bharadwaj U; Marin-Muller C; Li M; Chen C; Yao Q Mol Cancer; 2011 Aug; 10():106. PubMed ID: 21880146 [TBL] [Abstract][Full Text] [Related]
6. Benzo[b]furan derivatives induces apoptosis by targeting the PI3K/Akt/mTOR signaling pathway in human breast cancer cells. Kamal A; Lakshma Nayak V; Nagesh N; Vishnuvardhan MV; Subba Reddy NV Bioorg Chem; 2016 Jun; 66():124-31. PubMed ID: 27149364 [TBL] [Abstract][Full Text] [Related]
7. AMR-Me inhibits PI3K/Akt signaling in hormone-dependent MCF-7 breast cancer cells and inactivates NF-κB in hormone-independent MDA-MB-231 cells. Rabi T; Huwiler A; Zangemeister-Wittke U Mol Carcinog; 2014 Jul; 53(7):578-88. PubMed ID: 23475563 [TBL] [Abstract][Full Text] [Related]
8. Casticin induces leukemic cell death through apoptosis and mitotic catastrophe. Shen JK; Du HP; Yang M; Wang YG; Jin J Ann Hematol; 2009 Aug; 88(8):743-52. PubMed ID: 19139893 [TBL] [Abstract][Full Text] [Related]
9. Stellettin B induces apoptosis in human chronic myeloid leukemia cells via targeting PI3K and Stat5. Chen Y; Zhou Q; Zhang L; Zhong Y; Fan G; Zhang Z; Wang R; Jin M; Qiu Y; Kong D Oncotarget; 2017 Apr; 8(17):28906-28921. PubMed ID: 28423649 [TBL] [Abstract][Full Text] [Related]
10. PI3K/mTOR dual-inhibition with VS-5584 enhances anti-leukemic efficacy of ponatinib in blasts and Ph-negative LSCs of chronic myeloid leukemia. Kayabasi C; Yelken BO; Asik A; Okcanoglu TB; Sogutlu F; Gasimli R; Susluer SY; Saydam G; Avci CB; Gunduz C Eur J Pharmacol; 2021 Nov; 910():174446. PubMed ID: 34461124 [TBL] [Abstract][Full Text] [Related]
11. Dual PI3K/mTOR inhibitor NVP‑BEZ235 decreases the proliferation of doxorubicin‑resistant K562 cells. Li J; Wang X; Ma C; Xu S; Xu M; Yang J; Wang R; Xue L Mol Med Rep; 2021 Apr; 23(4):. PubMed ID: 34223631 [TBL] [Abstract][Full Text] [Related]
13. Pro-apoptotic and pro-autophagic effects of the Aurora kinase A inhibitor alisertib (MLN8237) on human osteosarcoma U-2 OS and MG-63 cells through the activation of mitochondria-mediated pathway and inhibition of p38 MAPK/PI3K/Akt/mTOR signaling pathway. Niu NK; Wang ZL; Pan ST; Ding HQ; Au GH; He ZX; Zhou ZW; Xiao G; Yang YX; Zhang X; Yang T; Chen XW; Qiu JX; Zhou SF Drug Des Devel Ther; 2015; 9():1555-84. PubMed ID: 25792811 [TBL] [Abstract][Full Text] [Related]
14. Anticancer Effect and Apoptosis Induction of Gambogic Acid in Human Leukemia Cell Line K562 In Vitro. Chen J; Zhou M; Zhang Q; Xu J; Ouyang J Med Sci Monit; 2015 Jun; 21():1604-10. PubMed ID: 26049398 [TBL] [Abstract][Full Text] [Related]
15. Discovery of anti-hepatoma agents from 1,4,5,6,7,8-hexahydropyrido[4,3-d]pyrimidine by inhibiting PI3K/AKT/NF-κB pathway activation. Zhou YQ; Sun Y; Luo HL; Gao ZF; Zhang HQ; Meng QG; Bai XY; Hou GG; Hou Y Eur J Med Chem; 2021 Dec; 225():113796. PubMed ID: 34450496 [TBL] [Abstract][Full Text] [Related]
16. Design, synthesis and biological evaluation of novel pyrazolochalcones as potential modulators of PI3K/Akt/mTOR pathway and inducers of apoptosis in breast cancer cells. Shaik AB; Rao GK; Kumar GB; Patel N; Reddy VS; Khan I; Routhu SR; Kumar CG; Veena I; Chandra Shekar K; Barkume M; Jadhav S; Juvekar A; Kode J; Pal-Bhadra M; Kamal A Eur J Med Chem; 2017 Oct; 139():305-324. PubMed ID: 28803046 [TBL] [Abstract][Full Text] [Related]
17. New thieno[3,2-d]pyrimidine-based derivatives: Design, synthesis and biological evaluation as antiproliferative agents, EGFR and ARO inhibitors inducing apoptosis in breast cancer cells. Farghaly AM; AboulWafa OM; Baghdadi HH; Abd El Razik HA; Sedra SMY; Shamaa MM Bioorg Chem; 2021 Oct; 115():105208. PubMed ID: 34365057 [TBL] [Abstract][Full Text] [Related]
18. Polyphenols isolated from Allium cepa L. induces apoptosis by suppressing IAP-1 through inhibiting PI3K/Akt signaling pathways in human leukemic cells. Han MH; Lee WS; Jung JH; Jeong JH; Park C; Kim HJ; Kim G; Jung JM; Kwon TK; Kim GY; Ryu CH; Shin SC; Hong SC; Choi YH Food Chem Toxicol; 2013 Dec; 62():382-9. PubMed ID: 24021570 [TBL] [Abstract][Full Text] [Related]
19. Molecular docking, anti-proliferative activity and induction of apoptosis in human liver cancer cells treated with androstane derivatives: Implication of PI3K/AKT/mTOR pathway. Kattan SW; Nafie MS; Elmgeed GA; Alelwani W; Badar M; Tantawy MA J Steroid Biochem Mol Biol; 2020 Apr; 198():105604. PubMed ID: 31982513 [TBL] [Abstract][Full Text] [Related]
20. Efficacy of the dual PI3K and mTOR inhibitor NVP-BEZ235 in combination with imatinib mesylate against chronic myelogenous leukemia cell lines. Xin P; Li C; Zheng Y; Peng Q; Xiao H; Huang Y; Zhu X Drug Des Devel Ther; 2017; 11():1115-1126. PubMed ID: 28435223 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]